Mirae Asset Global Investments Co., Ltd. Crispr Therapeutics Ag Transaction History

Mirae Asset Global Investments Co., Ltd.

$24 Billion
Q4 2024

A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 2,844 shares of CRSP stock, worth $141,403. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,844

Previous 3,080 7.66%

Holding current value

$141,403

Previous $144,000 22.92%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 27, 2025	SELL	$38.65 - $55.15 $9,121 - $13,015	-236 Reduced 7.66%	2,844 $111,000
Q3 2024 Oct 23, 2024	BUY	$44.62 - $62.75 $24,317 - $34,198	545 Added 21.5%	3,080 $144,000
Q2 2024 Jul 30, 2024	SELL	$51.17 - $68.18 $8.39 Million - $11.2 Million	-164,011 Reduced 98.48%	2,535 $136,000
Q1 2024 May 01, 2024	BUY	$60.67 - $89.12 $4.67 Million - $6.87 Million	77,053 Added 86.1%	166,546 $11.4 Million
Q4 2023 Jan 24, 2024	SELL	$38.62 - $72.18 $3.68 Million - $6.88 Million	-95,361 Reduced 51.59%	89,493 $5.6 Million
Q3 2023 Oct 26, 2023	BUY	$45.39 - $59.0 $783,340 - $1.02 Million	17,258 Added 10.3%	184,854 $8.39 Million
Q2 2023 Aug 10, 2023	SELL	$43.47 - $67.77 $155,231 - $242,006	-3,571 Reduced 2.09%	167,596 $9.41 Million
Q1 2023 May 04, 2023	BUY	$41.0 - $56.12 $310,165 - $424,547	7,565 Added 4.62%	171,167 $7.74 Million
Q4 2022 Feb 09, 2023	SELL	$39.19 - $65.67 $202,729 - $339,710	-5,173 Reduced 3.07%	163,602 $6.65 Million
Q3 2022 Nov 10, 2022	BUY	$61.1 - $83.78 $1.27 Million - $1.75 Million	20,829 Added 14.08%	168,775 $11 Million
Q2 2022 Jul 26, 2022	BUY	$43.23 - $73.83 $1.84 Million - $3.14 Million	42,564 Added 40.39%	147,946 $8.99 Million
Q1 2022 May 10, 2022	SELL	$53.19 - $79.24 $1.02 Million - $1.51 Million	-19,095 Reduced 15.34%	105,382 $6.62 Million
Q4 2021 Feb 08, 2022	BUY	$70.09 - $111.29 $2.51 Million - $3.99 Million	35,829 Added 40.42%	124,477 $9.43 Million
Q3 2021 Nov 15, 2021	BUY	$110.2 - $156.64 $1.89 Million - $2.68 Million	17,119 Added 23.93%	88,648 $9.92 Million
Q2 2021 Aug 11, 2021	BUY	$100.84 - $161.89 $4,739 - $7,608	47 Added 0.07%	71,529 $11.6 Million
Q1 2021 May 13, 2021	BUY	$110.72 - $210.04 $3.54 Million - $6.72 Million	32,015 Added 81.12%	71,482 $8.71 Million
Q4 2020 Feb 10, 2021	BUY	$79.67 - $173.23 $30,354 - $66,000	381 Added 0.97%	39,467 $6.04 Million
Q3 2020 Nov 12, 2020	BUY	$78.5 - $100.64 $981,721 - $1.26 Million	12,506 Added 47.05%	39,086 $3.27 Million
Q2 2020 Aug 11, 2020	BUY	$38.5 - $76.05 $550,896 - $1.09 Million	14,309 Added 116.61%	26,580 $1.95 Million
Q1 2020 May 12, 2020	BUY	$33.68 - $62.53 $44,356 - $82,352	1,317 Added 12.02%	12,271 $520,000
Q4 2019 Feb 12, 2020	BUY	$36.68 - $73.13 $61,989 - $123,589	1,690 Added 18.24%	10,954 $667,000
Q3 2019 Nov 12, 2019	BUY	$40.99 - $52.56 $379,731 - $486,915	9,264 New	9,264 $380,000

Others Institutions Holding CRSP

# of Institutions

494

Shares Held

64.3M

Call Options Held

1.68M

Put Options Held

1.95M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.88B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.

Account

Mirae Asset Global Investments Co., Ltd. Crispr Therapeutics Ag Transaction History